Answers are grounded in this paper and cite their sources.
A diprotic bis(β-thioketoimine) ligand precursor featuring a flexible 4,4’-methylbis(aniline) linker, H22, was synthesised via treatment of the corresponding bis(β-ketoimine) with Lawesson’s reagent. Lithiation of H22 and coordination with one equivalent of d-block metal(II) chlorides MCl2(THF)x (M = Fe, Co and Zn) yielded a corresponding series of homoleptic dinuclear complexes, [M2(μ-2)2]. X-ray diffraction analysis reveals a tetrahedral geometry for the two metals and a double-stranded helicate structure arising from inter-strand face-face π-stacking. These interactions create a helical ‘twist’ of ca. 70°. Utilising a bulky mononucleating β-thioketoiminate ligand, [3]–, the analogous series of heteroleptic monometallic complexes, [M(3)2] (M = Fe, Co and Zn), were prepared and characterised by spectroscopic and analytical techniques. To the best of our knowledge, these are the first complexes of Fe, Co and Zn supported by a bidentate β-thioketoiminate ligand to be structurally characterised by X-ray diffraction. A comprehensive DFT study of all complexes reveals a stronger M–S bonding compared to M–N due to a higher degree of covalency. Solution magnetic studies and Natural Bonding Orbital calculations on the mono- and dinuclear iron and cobalt complexes are consistent with high-spin tetrahedral Fe(II) and Co(II) centres, and cyclic voltammetry reveals both oxidation and reduction processes are accessible.
No takes yet. Share an insight, caveat, or question.
Allen et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: